Dean Mihas

Managing Director, GTCR

Mihas joined GTCR in 2001 and is a managing director of the firm. He is head of the healthcare group at GTCR and has been instrumental in building the firm’s expertise in life sciences and medical devices. He is currently a director of Cedar Gate Technologies, Cole-Parmer, ConvergEx, Cord Blood Registry, Crealta Pharmaceuticals, Curo Health Services, Devicor Medical Products, Maravai Life Sciences, Sterigenics and XIFIN. He was also a director of past GTCR investments including Actient Pharmaceuticals, ATI Physical Therapy, Ovation Pharmaceuticals, Managed Healthcare Associates and Polypore.